Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 75
Selected: 0
NCT IDTitle
NCT06980207A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017
NCT05110170Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®
NCT05862974A Dose-escalation Study of LPM3480392 in Chinese Healthy Subjects
NCT04571164A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PD
NCT03822065A Relative Bioavailability Food Effect Study of LY03005
NCT02271412Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005
NCT02728947Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's Disease
NCT04593511to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteers
NCT04922593Relative Bioavailability of LY03010 Compared to Listed Drug
NCT04627155A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003
NCT06793995Effect of Food and Age on the Pharmacokinetics of LY03017
NCT04973722A Study to Evaluate LY06006 and Prolia in Healthy Adults
NCT02603770Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers
NCT06474650Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets
NCT02055287Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective Disorder
NCT03533127A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer
NCT03450109A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer
NCT07516899Mass Balance Study of [14C] LPM3770164 in Healthy Participants
NCT02988024Pilot BA Study of New LY03005 vs Pristiq
NCT06216054Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects
NCT03733561A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro
NCT06426485To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets
NCT06496048Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC
NCT07230652A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
NCT06204120Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Abdominal Surgery
NCT07391566LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation
NCT07371065To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects
NCT06247410Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease
NCT02091388Bioavailability of LY03004 and Risperdal® Consta®
NCT05853354Comparative Efficacy, Safety, PK, and Immunogenicity Study
NCT05857449An Exploratory Study of LPM3480392 at Different Infusion Rates in Chinese Healthy Subjects
NCT06128837Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer
NCT02186769An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder
NCT04088604Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors
NCT06240546First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors.
NCT04973735A Phase I Study of LY-CovMab Injection in Chinese Healthy Subjects
NCT06556966A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects
NCT05140512Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®
NCT03751488A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients
NCT04572698A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration(wAMD)
NCT04629404A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD Patients
NCT06731868Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia
NCT03589066Pharmacokinetic Study of LY03003 in Patients With Parkinson's Disease
NCT03785652Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)
NCT04859569Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid Tumors
NCT04384666A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy Volunteers
NCT05865925Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid Tumors
NCT04630860A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD
NCT03427853A Study to Evaluate the Denosumab in Healthy Adults
NCT05970510A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.